Literature DB >> 27842207

Coffee consumption and the occurrence and intensity of metabolic syndrome: a cross-sectional study.

Edyta Suliga1, Dorota Kozieł2, Elżbieta Cieśla3, Dorota Rębak2, Stanisław Głuszek2.   

Abstract

The objective of the study was to investigate associations between coffee consumption and the occurrence of metabolic syndrome (MetS) and its components in individuals with a normal BMI, as well in those who are overweight and obese. The analysis was based on the data of 10,367 participants. The studies included a questionnaire interview, anthropometric measurements, blood pressure measurements and analyses of collected fasting-blood samples. In the overweight and obese participants, lower coffee consumption, compared with higher consumption was correlated with a significantly higher risk of abdominal obesity, hypertension, an abnormal glucose concentration, HDL cholesterol, triglycerides and MetS (p < .05). In the participants with a normal BMI, lower coffee consumption was related to the abdominal obesity, HDL cholesterol and MetS (p < .05). Individuals with a normal BMI may react slightly differently to nutritional factors modifying metabolism such as coffee, compared with those with excessive body mass.

Entities:  

Keywords:  BMI; Coffee consumption; metabolic syndrome

Mesh:

Substances:

Year:  2016        PMID: 27842207     DOI: 10.1080/09637486.2016.1256381

Source DB:  PubMed          Journal:  Int J Food Sci Nutr        ISSN: 0963-7486            Impact factor:   3.833


  9 in total

1.  The Relationship between Habitual Coffee Drinking and the Prevalence of Metabolic Syndrome in Taiwanese Adults: Evidence from the Taiwan Biobank Database.

Authors:  Meng-Ying Lu; Hsiao-Yang Cheng; Jerry Cheng-Yen Lai; Shaw-Ji Chen
Journal:  Nutrients       Date:  2022-04-29       Impact factor: 6.706

2.  Serum Vitamin D Level Related to Coffee Consumption in Korean Young Adults Using the 5th Korea National Health and Nutrition Examination Survey.

Authors:  Hee-Sook Lim; Hae-Hyeog Lee; Dong-Won Byun; Bora Lee; Temuulee Enkhbold; Tae-Hee Kim
Journal:  J Bone Metab       Date:  2017-11-30

Review 3.  Coffee Decreases the Risk of Endometrial Cancer: A Dose-Response Meta-Analysis of Prospective Cohort Studies.

Authors:  Alessandra Lafranconi; Agnieszka Micek; Fabio Galvano; Sabrina Rossetti; Lino Del Pup; Massimiliano Berretta; Gaetano Facchini
Journal:  Nutrients       Date:  2017-11-09       Impact factor: 5.717

4.  Coffee Intake Decreases Risk of Postmenopausal Breast Cancer: A Dose-Response Meta-Analysis on Prospective Cohort Studies.

Authors:  Alessandra Lafranconi; Agnieszka Micek; Paolo De Paoli; Sabrina Bimonte; Paola Rossi; Vincenzo Quagliariello; Massimiliano Berretta
Journal:  Nutrients       Date:  2018-01-23       Impact factor: 5.717

Review 5.  Do Coffee Polyphenols Have a Preventive Action on Metabolic Syndrome Associated Endothelial Dysfunctions? An Assessment of the Current Evidence.

Authors:  Kazuo Yamagata
Journal:  Antioxidants (Basel)       Date:  2018-02-04

6.  Coffee Consumption and Risk of Biliary Tract Cancers and Liver Cancer: A Dose-Response Meta-Analysis of Prospective Cohort Studies.

Authors:  Justyna Godos; Agnieszka Micek; Marina Marranzano; Federico Salomone; Daniele Del Rio; Sumantra Ray
Journal:  Nutrients       Date:  2017-08-28       Impact factor: 5.717

7.  The Effect of Bariatric Surgery on Weight Loss and Metabolic Changes in Adults with Obesity.

Authors:  Stanisław Głuszek; Arkadiusz Bociek; Edyta Suliga; Jarosław Matykiewicz; Magdalena Kołomańska; Piotr Bryk; Przemysław Znamirowski; Łukasz Nawacki; Martyna Głuszek-Osuch; Iwona Wawrzycka; Dorota Kozieł
Journal:  Int J Environ Res Public Health       Date:  2020-07-24       Impact factor: 3.390

8.  Lifestyle elements and risk of metabolic syndrome in adults.

Authors:  Edyta Suliga; Elzbieta Ciesla; Magdalena Lelonek; Agnieszka Piechowska; Stanislaw Gluszek
Journal:  PLoS One       Date:  2022-09-30       Impact factor: 3.752

Review 9.  Effects of Polyphenol Intake on Metabolic Syndrome: Current Evidences from Human Trials.

Authors:  Gemma Chiva-Blanch; Lina Badimon
Journal:  Oxid Med Cell Longev       Date:  2017-08-15       Impact factor: 6.543

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.